Robertson Stephen P.
Insider CIK 1837798 · AUPH EVP, General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AUPH Aurinia Pharmaceuticals In | S Sale | 2026-09-10 | 2026-09-11 | 11,939 | $15.95 | $190.4K | 588,848 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2026-09-10 | 2026-09-11 | 11,939 | $15.95 | $190.4K | 588,848 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2026-08-21 | 2026-08-25 | 20,975 | $16.97 | $355.9K | 600,787 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2026-08-21 | 2026-08-25 | 20,975 | $16.97 | $355.9K | 600,787 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2026-05-18 | 2026-05-20 | 115,541 | — | $0 | 621,402 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | F Tax w/h | 2026-03-02 | 2026-03-03 | 36,525 | $14.21 | $519.0K | 505,861 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2026-02-27 | 2026-03-03 | 98,813 | — | $0 | 98,813 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2026-02-27 | 2026-03-03 | 59,090 | — | $0 | 542,386 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | F Tax w/h | 2026-02-20 | 2026-02-23 | 34,638 | $14.40 | $498.8K | 483,296 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | F Tax w/h | 2026-01-02 | 2026-01-05 | 40,385 | $15.95 | $644.1K | 517,934 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2026-01-02 | 2026-01-05 | 48,558 | — | $0 | 557,434 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2025-03-04 | 2025-03-04 | 57,607 | $7.92 | $456.2K | 509,276 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2025-03-03 | 2025-03-04 | 102,406 | — | $0 | 631,755 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2025-03-03 | 2025-03-04 | 64,872 | $8.00 | $519.0K | 566,883 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2025-02-28 | 2025-03-04 | 128,438 | — | $0 | 128,438 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2025-02-28 | 2025-03-04 | 84,106 | — | $0 | 529,349 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2024-03-06 | 2024-03-07 | 57,745 | $5.60 | $323.4K | 443,824 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2024-02-20 | 2024-02-22 | 194,230 | — | $0 | 501,569 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2023-03-02 | 2024-02-22 | 19,644 | $8.78 | $172.5K | 303,122 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | S Sale | 2023-03-02 | 2023-03-06 | 19,402 | $8.94 | $173.5K | 303,364 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2023-03-02 | 2023-03-06 | 204,810 | — | $0 | 322,766 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2022-03-02 | 2022-03-04 | 178,063 | — | $0 | 178,063 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award deriv | 2022-03-02 | 2022-03-04 | 104,080 | — | $0 | 104,080 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | A Award | 2022-03-02 | 2022-03-04 | 8,500 | — | $0 | 11,682 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | P Buy | 2021-01-28 | 2021-01-29 | 900 | $16.14 | $14.5K | 2,720 | SEC↗ |